Research Article
Changes in the Monocytic Subsets CD14dimCD16+ and CD14++CD16− in Chronic Systolic Heart Failure Patients
Table 1
Clinical characteristics of heart failure patients and controls.
| | Clinical characteristics | HF patients () | Control ) |
| | Age (years; mean ± sd) | 58.1 ± 13.9 | 59.7 ± 6.4 | | Sex (male/female) | 45/14 | 15/14 | | NYHA 1 | 7 | N/A | | NYHA 2 | 39 | N/A | | NYHA 3 | 11 | N/A | | NYHA 4 | 2 | N/A | | Ischemic etiology | 30 (51%) | N/A | | Diabetes mellitus | 21 (35.6%) | 4 (14%) | | β-blockers (n/%) | 59 (100%) | 2 (7%) | | ACE-I +/or ARB (n/%) | 56 (95%) | 2 (7%) | | Aldosterone antagonist (n/%) | 18 (30.5%) | None | | Statins (n/%) | 44 (75%) | N/A | | LV ejection fraction (%, SD) | 26.29 ± 8.63 | N/A | | Mean hemoglobin (g/dL, mean ± sd) | 12.9 ± 1.8 | N/A | | Mean creatinine (mg/dL, mean ± sd) | 1.18 ± 0.06 | N/A | | Creatinine clearance (CCT, mean ± sd) | 81 ± 4.4 cm/min | N/A |
|
|
